Surgery remains central for managing primary melanoma, and is an important element of integrated multidisciplinary care in advanced disease, particularly for patients with resectable metastases. The field will undergo further change as clinical trials address the relationships between surgery, radiotherapy and systemic therapy for patients with high-risk, early-stage and advanced melanoma.
Jennifer A. Wargo, Rodabe N. Amaria, Merrick I. Ross, Robyn P.M. Saw, Jeffrey E. Gershenwald, Patrick Hwu, Sapna P. Patel, Isabella Claudia Glitza, Adi Diab, Richard Kefford, Richard A Scolyer, Helen Rizos, John F. Thompson, Kerwin F. Shannon, Andrew J. Spillane, Matteo S. Carlino, Alex Guminski, Lauren Simpson, Michael A. Davies, Georgina V. Long
Alexander M. Menzies, Elisa A. Rozeman, Rodabe Navroze Amaria, Alexander C. Huang, Richard A Scolyer, Michael T. Tetzlaff, Bart A. van de Wiel, Serigne Lo, Ahmad A. Tarhini, Hussein Tawbi, Elizabeth M. Burton, Giorgos C. Karakousis, Paolo A. Ascierto, Andrew J. Spillane, Michael A. Davies, Alexander Christopher Jonathan Van Akkooi, Tara C. Mitchell, Georgina V. Long, Jennifer A. Wargo, Christian U. Blank
Discussion(0)
No comments yet. Be the first to comment.